Nath Bio-Genes (India) Ltd
Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]
- Market Cap ₹ 330 Cr.
- Current Price ₹ 174
- High / Low ₹ 264 / 167
- Stock P/E 8.15
- Book Value ₹ 339
- Dividend Yield 1.15 %
- ROCE 6.85 %
- ROE 6.23 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.51 times its book value
Cons
- The company has delivered a poor sales growth of 3.74% over past five years.
- Tax rate seems low
- Company has a low return on equity of 5.55% over last 3 years.
- Dividend payout has been low at 4.87% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109 | 136 | 143 | 127 | 142 | 171 | 206 | 246 | 271 | 230 | 234 | 248 | 351 | |
89 | 102 | 109 | 103 | 113 | 131 | 163 | 191 | 204 | 193 | 185 | 197 | 297 | |
Operating Profit | 20 | 34 | 35 | 25 | 29 | 40 | 43 | 55 | 67 | 37 | 49 | 50 | 54 |
OPM % | 18% | 25% | 24% | 19% | 20% | 24% | 21% | 22% | 25% | 16% | 21% | 20% | 15% |
1 | 1 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | -87 | 1 | 4 | 4 | |
Interest | 4 | 4 | 5 | 6 | 10 | 10 | 5 | 7 | 9 | 11 | 10 | 9 | 9 |
Depreciation | 5 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 |
Profit before tax | 12 | 26 | 26 | 15 | 17 | 30 | 39 | 49 | 57 | -63 | 36 | 42 | 46 |
Tax % | 4% | 5% | 4% | 6% | 3% | 2% | 1% | -4% | 2% | 6% | 3% | 5% | |
12 | 24 | 25 | 14 | 16 | 29 | 38 | 50 | 56 | -67 | 35 | 40 | 44 | |
EPS in Rs | 7.34 | 15.18 | 15.87 | 8.85 | 10.17 | 15.48 | 20.22 | 26.56 | 29.29 | -35.43 | 18.51 | 21.14 | 23.12 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 7% | -6% | 11% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 4% |
3 Years: | -3% |
TTM: | 7% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | -1% |
3 Years: | -13% |
TTM: | 7% |
Stock Price CAGR | |
---|---|
10 Years: | 2% |
5 Years: | -12% |
3 Years: | -14% |
1 Year: | -15% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 7% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 16 | 16 | 16 | 16 | 16 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
Reserves | 41 | 66 | 91 | 105 | 287 | 450 | 489 | 539 | 594 | 523 | 554 | 592 | 624 |
19 | 23 | 22 | 59 | 74 | 33 | 58 | 70 | 101 | 93 | 105 | 108 | 127 | |
67 | 85 | 97 | 87 | 78 | 69 | 80 | 102 | 75 | 105 | 114 | 158 | 58 | |
Total Liabilities | 143 | 190 | 226 | 267 | 455 | 571 | 646 | 730 | 790 | 740 | 793 | 877 | 829 |
18 | 17 | 13 | 30 | 207 | 211 | 232 | 246 | 247 | 245 | 244 | 249 | 251 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
120 | 168 | 208 | 231 | 243 | 355 | 409 | 479 | 538 | 490 | 544 | 622 | 572 | |
Total Assets | 143 | 190 | 226 | 267 | 455 | 571 | 646 | 730 | 790 | 740 | 793 | 877 | 829 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 6 | -14 | 3 | -47 | -23 | 9 | 1 | 17 | 38 | 75 | ||
-16 | -2 | -17 | -4 | -4 | -20 | -14 | -10 | -20 | -3 | -27 | ||
1 | -4 | 30 | 5 | 90 | 20 | 6 | 16 | -22 | -2 | -10 | ||
Net Cash Flow | -0 | -1 | -0 | 5 | 39 | -23 | 1 | 7 | -25 | 34 | 38 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 70 | 95 | 114 | 130 | 133 | 175 | 191 | 159 | 147 | 136 | 152 | 139 |
Inventory Days | 3,840 | 4,743 | 4,388 | |||||||||
Days Payable | 1,309 | 1,406 | 586 | |||||||||
Cash Conversion Cycle | 70 | 95 | 114 | 130 | 2,665 | 3,512 | 191 | 159 | 147 | 136 | 3,954 | 139 |
Working Capital Days | 167 | 179 | 242 | 383 | 398 | 515 | 544 | 519 | 585 | 573 | 578 | 498 |
ROCE % | 24% | 33% | 26% | 14% | 10% | 9% | 8% | 9% | 10% | 5% | 7% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
28 Oct - Transcript of Conference call held on 24th October 2024.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
28 Oct - Submission of compliance certificate for Q2 2024.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
25 Oct - Audio Transcript of Earning Call held on 24th October 2024
-
Announcement under Regulation 30 (LODR)-Investor Presentation
23 Oct - Presentation on Unaudited financial results as on 30th Sept 2024.
-
Announcement under Regulation 30 (LODR)-Change in Management
23 Oct - Board approved unaudited financial results and CFO changes.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
Concalls
-
Oct 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPT
-
Oct 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Apr 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
Apr 2019TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into